Impact of social vulnerability index on patients with alcohol-related liver disease

被引:0
|
作者
Jain, Ayushi [1 ]
Wellner, Michael R. [2 ]
Peng, Jing [3 ]
Ma, Jianing [3 ]
Allen, Kenneth D. [2 ]
Mcshane, Chelsey [2 ]
Ramsey, Mitchell L. [2 ]
Mumtaz, Khalid [2 ]
Kelly, Sean G. [2 ]
Conteh, Lanla F. [2 ]
Kirkpatrick, Robert [2 ]
Sobotka, Lindsay A. [2 ]
机构
[1] Ohio State Univ, Wexner Med Ctr, Dept Internal Med, Columbus, OH USA
[2] Ohio State Wexner Med Ctr, Div Gastroenterol Hepatol & Nutr, Dept Internal Med, Columbus, OH USA
[3] Ohio State Univ, Dept Biostat, Columbus, OH USA
关键词
alcohol user disorder; alcohol related liver disease; social vulnerability index; hospitalization outcomes; CIRRHOSIS;
D O I
10.1016/j.alcohol.2024.08.005
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: Alcohol related liver disease (ALD) affects diverse communities with individual and social characteristics that can impact outcomes. The social vulnerability index (SVI) assigns a score between 0 and 1, where higher scores represent an increased risk of social vulnerability. We sought to assess the impact of SVI on outcomes of patients hospitalized with ALD with access to social support services. Methods and materials: Hospitalizations for ALD at our institution between March and August 2019 were reviewed. All patients were assigned an SVI score based on their residential census tract. Per our standard practice, patients were screened by care coordinators to identify needs for rehabilitation counseling, and care coordination after discharge. Demographics, hepatic decompensation, critical care needs, readmission, and mortality were compared. Results: Among 73 patients admitted for alcoholic hepatitis, 32 had a low SVI and 42 had a high SVI. African American patients were more likely to have a higher SVI (35% vs 0%, p=<0.001). No significant difference in outcomes based on SVI was noted. There were 393 patients admitted for alcoholic cirrhosis including 166 with a low SVI and 227 with a high SVI. Patients that were African American (23.6% vs 5.5%, p=<0.001) or disabled (41.4% vs 29.5%, p = 0.008) had a higher SVI. No significant difference in outcomes based on SVI was noted. Conclusion: Most patients admitted for ALD had a high SVI; however, SVI did not impact hospitalization outcomes. (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:147 / 150
页数:4
相关论文
共 50 条
  • [31] Risk of alcohol-related liver disease in offspring of individuals with alcohol-related liver disease: a nationwide cohort study in Denmark
    Jepsen, Peter
    Crooks, Colin
    Morling, Joanne
    Kraglund, Frederik
    Kann, Anna Emilie
    West, Joe
    Askgaard, Gro
    JOURNAL OF HEPATOLOGY, 2023, 78 : S160 - S161
  • [32] Impact of acute alcohol consumption on circulating microbiome in asymptomatic alcohol-related liver disease
    Israelsen, Mads
    Alvarez-Silva, Camila
    Madsen, Bjorn Staehr
    Hansen, Camilla Dalby
    Torp, Nikolaj Christian
    Johansen, Stine
    Hansen, Johanne Kragh
    Lindvig, Katrine Prier
    Insonere, Jeanlouis
    Riviere, Virginie
    Juel, Helene Baek
    Brejnrod, Asker
    Jensen, Lars Juhl
    Thiele, Maja
    Lelouvier, Benjamin
    Hansen, Torben
    Arumugam, Manimozhiyan
    Krag, Aleksander
    MicrobLiver Consortium
    GALAXY Consortium
    GUT, 2024, 73 (06) : 1041 - 1044
  • [33] Acute-on-chronic liver failure in patients with alcohol-related liver disease
    Gustot, Thierry
    Jalan, Rajiv
    JOURNAL OF HEPATOLOGY, 2019, 70 (02) : 319 - 327
  • [34] Feasibility and reproducibility of liver and pancreatic stiffness in patients with alcohol-related liver disease
    Conti, Clara Benedetta
    Weiler, Nina
    Casazza, Giovanni
    Schrecker, Christopher
    Schneider, Maximillian
    Muecke, Marcus M.
    Queck, Alexander
    Herrmann, Eva
    Conte, Dario
    Colombo, Massimo
    Zeuzem, Stefan
    Fraquelli, Mirella
    Friedrich-Rust, Mireen
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (07) : 1023 - 1029
  • [35] Psychosocial functioning in patients with alcohol-related liver disease post liver transplantation
    Pegum, Nell
    Connor, Jason P.
    Young, Ross McD.
    Feeney, Gerald F. X.
    ADDICTIVE BEHAVIORS, 2015, 45 : 70 - 73
  • [36] The Pattern of Alcohol Consumption and the Severity of Alcohol-related Liver Disease in Patients Visiting the Liver Clinic
    Samjo, Shoukat Ali
    Abbas, Zaigham
    Asim, Muhammad
    Tahir, Kanwal
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (03)
  • [37] Identification of risk factors for alcohol relapse in liver transplant patients with alcohol-related liver disease
    Turan, Dilara
    Gunsar, Fulya
    Harputluoglu, Murat
    Kabacam, Gokhan
    Gokcan, Hale
    Akyildiz, Murat
    Akarsu, Mesut
    Adali, Gupse
    Ari, Derya
    Turan, Ilker
    Danis, Nilay
    Akarca, Ulus
    Durmazer, Esra
    Gencdal, Genco
    Aladag, Murat
    Gulsen, Murat Taner
    Sarikaya, Ozan
    Yilmaz, Volkan
    Karasu, Zeki
    Idilman, Ramazan
    Kayhan, Meral Akdogan
    JOURNAL OF HEPATOLOGY, 2023, 78 : S181 - S182
  • [38] Understanding Alcohol Relapse in Liver Transplant Patients With Alcohol-Related Liver Disease: A Comprehensive Review
    Shinde, Shreyashee S.
    Chakole, Swarupa
    Humane, Sonal
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [39] Travel distance and social vulnerability index: Impact on liver-related mortality among patients with end-stage liver disease
    Yang, Jason
    Endo, Yutaka
    Moazzam, Zorays
    Lima, Henrique A.
    Woldesenbet, Selamawit
    Alaimo, Laura
    Azap, Lovette
    Shaikh, Chanza F.
    Munir, Muhammad Musaab
    Katayama, Erryk
    Sasaki, Kazunari
    Pawlik, Timothy M.
    CLINICAL TRANSPLANTATION, 2023, 37 (09)
  • [40] PSYCHOSOCIAL VULNERABILITY DOES NOT PREDICT ADVERSE OUTCOMES AFTER LIVER TRANSPLANT (LT) IN PATIENTS WITH ALCOHOL-RELATED LIVER DISEASE (ALD).
    Matthews, Lindsay
    Hause, Jessica
    Daniel, Kimberly E.
    Deiss-Yehiely, Nimrod
    Lightbourne, Christina
    Garvey, Maureen
    Rice, John P.
    Foley, David P.
    Lucey, Michael R.
    HEPATOLOGY, 2021, 74 : 247A - 248A